Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Placebo/ CONCERTA (methylphenidate HCl), CONCERTA (methylphenidate HCl) / Placebo; Drug
Lead sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC; Industry
Eligibility: 9 Years to 12 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Irvine, California • Houston, Texas

Conditions: Autism Spectrum Disorders, Hyperactivity
Interventions: Omega-3 Fatty Acids, Placebo; Drug · Other
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 5 Years to 8 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Multiple Locations, Maryland

Conditions: Autism Spectrum Disorder
Interventions: MINDful TIME, Mindfulness Mobile App; Behavioral
Lead sponsor: Nicole Matthews, Ph.D.; Other
Eligibility: 13 Years to 18 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Autism Spectrum Disorder, Mental Health Services
Interventions: Access to a Family Service Navigator and Treatment Support System; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Autistic Disorder
Interventions: Interdisciplinary process drama; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 3 Years to 4 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Tourette Syndrome
Interventions: SCI-110, Placebo; Drug · Other
Lead sponsor: Neurothera Labs Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: TBI (Traumatic Brain Injury), Brain Injuries, Stress, Attention Deficit, Executive Dysfunction
Interventions: State regulation skill training, Treatment-as-usual; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: HLD200 methylphenidate hydrochloride (MPH) Capsules, Placebo; Drug
Lead sponsor: Ironshore Pharmaceuticals and Development, Inc; Other
Eligibility: 6 Years to 12 Years
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 21
States / cities: Newport Beach, California • Bradenton, Florida • Gainesville, Florida + 16 more

Conditions: Autism Spectrum Disorder, Autism, Asperger Syndrome
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 12 Years to 45 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 1
States / cities: Stanford, California

Conditions: Autism
Interventions: Pathways and Resources for Engagement and Participation (PREP); Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 13 Years to 21 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Attention Deficit Disorders With Hyperactivity
Interventions: Pharmacogenomics report; Diagnostic Test
Lead sponsor: Clinical and Translational Genome Research Institute, Inc.; Other
Eligibility: 6 Years to 18 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: Hamilton, New Jersey • Mountainside, New Jersey • Toms River, New Jersey

Conditions: Rett Syndrome
Interventions: NGN-401; Genetic
Lead sponsor: Neurogene Inc.; Industry
Eligibility: 3 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 13
States / cities: Birmingham, Alabama • Oakland, California • Aurora, Colorado + 10 more

Conditions: Autism
Interventions: Hyperbaric Oxygenation Therapy; Procedure
Lead sponsor: The Center for Autism and Related Disorders; Other
Eligibility: 2 Years to 14 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Tarzana, California

Conditions: Depression, Conduct Disorder
Interventions: Bridges to High School Project; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 10 Years to 15 Years
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2002
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Prematurity, Very Preterm Maturity of Infant
Interventions: SNOO Smart Sleeper, Traditional bassinet; Device
Lead sponsor: Columbia University; Other
Eligibility: 1 Week to 12 Weeks
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Tuberous Sclerosis Complex, Self-injury, Autism
Interventions: Sirolimus, Everolimus; Drug
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 2 Years to 30 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autism, Development Delay, Typical Development
Interventions: Virtual Reality, Standard of Care; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 8 Years to 19 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Parkinson Disease, Huntington Disease, Autistic Spectrum Disorders, Fragile X Syndrome, Alzheimer Disease, Mild Cognitive Impairment
Interventions: [18F]FPEB; Drug
Lead sponsor: Institute for Neurodegenerative Disorders; Other
Eligibility: 18 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Developmental Delay Disorders, Chromosome Deletion, Mental Retardation, Sleep Disorders, Circadian Rhythm, Self Injurious Behavior
Interventions: dTR Melatonin (NIH CC PDS), Phototherapy (Bright Light), Melatonin CR; Drug · Device
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 3 Years to 45 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Autism Spectrum Disorder
Interventions: Social Enhancement Intervention, Parent Education; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 24 Months to 42 Months
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autism Spectrum Disorder
Interventions: Parent-based Crisis Prevention Institute (CPI) physical management training program (P-CPI); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 5 Years to 12 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Lexington, Massachusetts

Conditions: Hyperbilirubinemia, Neonatal, Jaundice, Neonatal, Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
Interventions: Aggressive Phototherapy 501-750g, Aggressive Phototherapy 751-1000g, Conservative Phototherapy 501-750g, Conservative Phototherapy 751-1000g; Procedure
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 12 Hours to 36 Hours
Enrollment: 1,974 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 13 more

Conditions: Autism Spectrum Disorder, Down Syndrome
Interventions: Bicycle Training Intervention; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 9 Years to 18 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Southbend, Indiana • Ann Arbor, Michigan • Grand Rapids, Michigan

Conditions: Autism Spectrum Disorder
Interventions: Surviving and Thriving in the Real World, Program for the Education and Enrichment of Relational Skills; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 14 Years to 21 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Search by objective public record fields.

Lab School Day Study for CONCERTA of Older Children With ADHD

Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder

Telehealth Mindfulness-based Intervention for Adolescents With Autism Spectrum Disorder and Their Caregivers

Testing a Family Service Navigator Program for Low-resourced Families of Young Children With Autism Spectrum Disorder

Social Skills in Children With ASD and Process Drama

SCI-110 in the Treatment of Tourette Syndrome

Brain Markers of Improvements in Cognitive Functioning

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

The Feasibility of a Remote Problem-Solving Intervention for Autistic Adolescents or Young Adults and a Caregiver

Pharmacogenomics for Improving Pediatric ADHD Treatment

A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

Effects of Hyperbaric Oxygenation Therapy on Adaptive, Aberrant and Stereotyped Behaviors in Children With Autism

Prevention of School Dropout for Mexican American Adolescents

Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants

Rapalogues for Autism Phenotype in TSC: A Feasibility Study

Use of Virtual Reality Game Playing During Venipuncture

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

Treatment Strategies for Children With Smith-Magenis Syndrome

Social Cognitive Development in Young Children With Autism

CPI Training for Parents of Children With ASD

Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight

A Bicycle Training Intervention

Daily Living Skills Intervention for 9th and 10th Graders With Autism Spectrum Disorders